{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:36:39Z","timestamp":1763015799965,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005612","name":"Shionogi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.cgh.2020.03.032","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T20:36:15Z","timestamp":1584736575000},"page":"2600-2608.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Lusutrombopag Is Safe and Efficacious for Treatment of Thrombocytopenia in Patients With and Without Hepatocellular Carcinoma"],"prefix":"10.1016","volume":"18","author":[{"given":"Naim","family":"Alkhouri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Imawari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Namiki","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Osaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimitsu","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7196-5836","authenticated-orcid":false,"given":"Roy","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6393-6995","authenticated-orcid":false,"given":"Franco","family":"Trevisani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2020.03.032_bib1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cgh.2020.03.032_bib2","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/hep.27222","article-title":"Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?","volume":"60","author":"El-Serag","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2020.03.032_bib3","doi-asserted-by":"crossref","first-page":"e1431","DOI":"10.1097\/MD.0000000000001431","article-title":"The prognostic value of platelet count in patients with hepatocellular carcinoma: a systematic review and meta-analysis","volume":"94","author":"Pang","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.cgh.2020.03.032_bib4","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1445-2197.2012.06241.x","article-title":"Role of splenectomy in patients with hepatocellular carcinoma and hypersplenism","volume":"83","author":"Kim","year":"2013","journal-title":"Aust N Z J Surg"},{"key":"10.1016\/j.cgh.2020.03.032_bib5","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2036.2009.04182.x","article-title":"Systematic review: portal vein thrombosis in cirrhosis","volume":"31","author":"Tsochatzis","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2020.03.032_bib6","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/liv.13988","article-title":"Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: the more, the worse?","volume":"39","author":"Mahringer-Kunz","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2020.03.032_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10110450","article-title":"Cancer-associated thrombosis in cirrhotic patients with hepatocellular carcinoma","volume":"10","author":"Zanetto","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cgh.2020.03.032_bib8","first-page":"153","article-title":"Current management of hepatocellular carcinoma","volume":"10","author":"Crissien","year":"2014","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.03.032_bib9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4329\/wjr.v6.i5.160","article-title":"Partial splenic artery embolization in cirrhotic patients","volume":"6","author":"Hadduck","year":"2014","journal-title":"World J Radiol"},{"key":"10.1016\/j.cgh.2020.03.032_bib10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12957-016-0802-z","article-title":"Emergency endoscopic variceal ligation following variceal rupture in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis: a retrospective study","volume":"14","author":"Kawai","year":"2016","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.cgh.2020.03.032_bib11","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.dld.2018.03.014","article-title":"When and how should we perform a biopsy for HCC in patients with liver cirrhosis in 2018? A review","volume":"50","author":"Russo","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2020.03.032_bib12","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/liv.13317","article-title":"Thrombocytopenia in chronic liver disease","volume":"37","author":"Peck-Radosavljevic","year":"2017","journal-title":"Liver Int"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2020.03.032_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2036.2007.03510.x","article-title":"Review article: thrombocytopenia in chronic liver disease","volume":"26","author":"Poordad","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2020.03.032_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3410\/M2-5","article-title":"Platelet transfusions: trigger, dose, benefits, and risks","volume":"2","author":"Blumberg","year":"2010","journal-title":"F1000 Med Rep"},{"key":"10.1016\/j.cgh.2020.03.032_bib15","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.chest.2016.04.004","article-title":"Platelet transfusion practices in the ICU: data from a large transfusion registry","volume":"150","author":"Ning","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.cgh.2020.03.032_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40265-015-0525-4","article-title":"Lusutrombopag: first global approval","volume":"76","author":"Kim","year":"2016","journal-title":"Drugs"},{"year":"2018","series-title":"MULPLETA\u00ae (lusutrombopag tablets) for oral use [prescribing information]","key":"10.1016\/j.cgh.2020.03.032_bib17"},{"year":"2019","series-title":"Kennisgeving Overeenkomstig Artikel 297 Van Het Vweu [Dutch]","key":"10.1016\/j.cgh.2020.03.032_bib19"},{"key":"10.1016\/j.cgh.2020.03.032_bib20","first-page":"1254A","article-title":"Lusutrombopag for treatment of thrombocytopenia in patients with chronic liver disease who are undergoing non-emergency invasive procedures: results from an international phase 3, randomized, double-blind, placebo-controlled study (L-PLUS 2) (abstract)","volume":"66","author":"Afdhal","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2020.03.032_bib21","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cgh.2018.11.047","article-title":"Lusutrombopag reduces need for platelet transfusion in patients with thrombocytopenia undergoing invasive procedures","volume":"17","author":"Hidaka","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.03.032_bib22","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/hep.30561","article-title":"Lusutrombopag for the treatment of thrombocytopenia in patients with chronic liver disease undergoing invasive procedures (L-PLUS 2)","volume":"70","author":"Peck-Radosavljevic","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2020.03.032_bib23","doi-asserted-by":"crossref","first-page":"4576276","DOI":"10.1155\/2018\/4576276","article-title":"Rupture of hepatocellular carcinoma after transarterial chemoembolization followed by massive gastric bleeding","volume":"2018","author":"Nishida","year":"2018","journal-title":"Case Reports Hepatol"},{"key":"10.1016\/j.cgh.2020.03.032_bib24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1634\/theoncologist.6-1-14","article-title":"Radiofrequency ablation of malignant liver tumors","volume":"6","author":"Curley","year":"2001","journal-title":"Oncologist"},{"key":"10.1016\/j.cgh.2020.03.032_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00535-018-1499-2","article-title":"A\u00a0randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation","volume":"54","author":"Tateishi","year":"2019","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.cgh.2020.03.032_bib26","first-page":"40","article-title":"Efficacy of oral thrombopoietin receptor agonist lusutrombopag in chronic liver disease by underlying disease aetiology (abstract)","volume":"7","author":"Alkhouri","year":"2019","journal-title":"Eur Med J Hepatol"},{"key":"10.1016\/j.cgh.2020.03.032_bib27","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1056\/NEJMoa1110709","article-title":"Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia","volume":"367","author":"Afdhal","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2020.03.032_bib28","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.gastro.2018.05.025","article-title":"Avatrombopag before procedures reduces need for platelet transfusion in patients with chronic liver disease and thrombocytopenia","volume":"155","author":"Terrault","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2020.03.032_bib29","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1080\/09537104.2018.1542125","article-title":"Chronic liver disease, thrombocytopenia and procedural bleeding risk; are novel thrombopoietin mimetics the solution?","volume":"30","author":"Olson","year":"2018","journal-title":"Platelets"},{"issue":"Suppl\u00a01S","key":"10.1016\/j.cgh.2020.03.032_bib30","doi-asserted-by":"crossref","first-page":"e690","DOI":"10.1016\/S0618-8278(19)31375-1","article-title":"Hepatocellular carcinoma does not impact the efficacy of avatrombopag in increasing platelet counts and reducing platelet transfusions or rescue procedures for bleeding in chronic liver disease patients with thrombocytopenia (abstract)","volume":"70","author":"Alkhouri","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2020.03.032_bib31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.dld.2018.06.005","article-title":"Thrombopoietin receptor agonists and risk of portal vein thrombosis in patients with liver disease and thrombocytopenia: a meta-analysis","volume":"51","author":"Loffredo","year":"2019","journal-title":"Dig Liver Dis"},{"year":"2019","series-title":"PROMACTA\u00ae (eltrombopag) tablets, for oral use, PROMACTA\u00ae (eltrombopag) for oral suspension [prescribing information]","key":"10.1016\/j.cgh.2020.03.032_bib32"},{"key":"10.1016\/j.cgh.2020.03.032_bib33","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s40262-019-00770-4","article-title":"Pharmacokinetic\/pharmacodynamic modelling and simulation of lusutrombopag, a novel thrombopoietin receptor agonist, for the treatment of thrombocytopenia in patients with chronic liver disease undergoing invasive procedures","volume":"58","author":"Katsube","year":"2019","journal-title":"Clin Pharmacokinet"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235652030344X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235652030344X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:32:55Z","timestamp":1761543175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154235652030344X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S154235652030344X"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2020.03.032","relation":{},"ISSN":["1542-3565"],"issn-type":[{"type":"print","value":"1542-3565"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lusutrombopag Is Safe and Efficacious for Treatment of Thrombocytopenia in Patients With and Without Hepatocellular Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2020.03.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the AGA Institute. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}